These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24648803)

  • 21. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Lima FV; Singh S; Parikh PB; Gruberg L
    Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and outcomes of contrast-induced AKI following computed tomography.
    Weisbord SD; Mor MK; Resnick AL; Hartwig KC; Palevsky PM; Fine MJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1274-81. PubMed ID: 18463172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies.
    Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P
    Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
    Murat SN; Kurtul A; Yarlioglues M
    Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
    Clase CM; Barzilay J; Gao P; Smyth A; Schmieder RE; Tobe S; Teo KK; Yusuf S; Mann JF
    Kidney Int; 2017 Mar; 91(3):683-690. PubMed ID: 27927602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
    Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
    Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes].
    Kobalava ZD; Villevalde SV; Gaskina AA; Mayskov VV; Moiseev VS
    Ter Arkh; 2015; 87(6):50-55. PubMed ID: 26281196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome.
    Leung KC; Pannu N; Tan Z; Ghali WA; Knudtson ML; Hemmelgarn BR; Tonelli M; James MT;
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1840-8. PubMed ID: 25318754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
    Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
    Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
    Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
    Helgason D; Long TE; Helgadottir S; Palsson R; Sigurdsson GH; Gudbjartsson T; Indridason OS; Gudmundsdottir IJ; Sigurdsson MI
    J Nephrol; 2018 Oct; 31(5):721-730. PubMed ID: 30187381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study.
    Gupta RK; Kapoor A; Tewari S; Sinha N; Sharma RK
    Indian Heart J; 1999; 51(5):521-6. PubMed ID: 10721643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single cystatin C determination before coronary angiography can predict short and long-term adverse events.
    Budano C; Andreis A; De Filippo O; Bissolino A; Lanfranco G; Usmiani T; Gai M; Levis M; Bergamasco L; Marra S; Rinaldi M; Ferrari GM
    Int J Cardiol; 2020 Feb; 300():73-79. PubMed ID: 31619362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-angiotensin blockade is associated with increased mortality after vascular surgery.
    Railton CJ; Wolpin J; Lam-McCulloch J; Belo SE
    Can J Anaesth; 2010 Aug; 57(8):736-44. PubMed ID: 20524103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.